
Jake Minh Vu
Examiner (ID: 8807, Phone: (571)272-8148 , Office: P/1618 )
| Most Active Art Unit | 1618 |
| Art Unit(s) | 1618 |
| Total Applications | 1117 |
| Issued Applications | 361 |
| Pending Applications | 132 |
| Abandoned Applications | 637 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18271690
[patent_doc_number] => 20230092932
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => COMPOSITIONS AND METHODS FOR STABILIZING COELENTERAZINE AND ANALOGS AND DERIVATIVES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/057578
[patent_app_country] => US
[patent_app_date] => 2022-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27676
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18057578
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/057578 | COMPOSITIONS AND METHODS FOR STABILIZING COELENTERAZINE AND ANALOGS AND DERIVATIVES THEREOF | Nov 20, 2022 | Pending |
Array
(
[id] => 19586270
[patent_doc_number] => 20240383827
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-21
[patent_title] => DIFLUOROCARBENE RADIOSYNTHESIS
[patent_app_type] => utility
[patent_app_number] => 18/694241
[patent_app_country] => US
[patent_app_date] => 2022-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22032
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18694241
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/694241 | DIFLUOROCARBENE RADIOSYNTHESIS | Sep 21, 2022 | Pending |
Array
(
[id] => 18433468
[patent_doc_number] => 20230180762
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => COMPOSITION AND METHODS FOR ANTIMICROBIAL ARTICLES
[patent_app_type] => utility
[patent_app_number] => 17/947370
[patent_app_country] => US
[patent_app_date] => 2022-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6842
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17947370
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/947370 | COMPOSITION AND METHODS FOR ANTIMICROBIAL ARTICLES | Sep 18, 2022 | Pending |
Array
(
[id] => 20038611
[patent_doc_number] => 20250176833
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-05
[patent_title] => FC DOMAIN IMAGING PROBES AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/691390
[patent_app_country] => US
[patent_app_date] => 2022-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7148
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18691390
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/691390 | FC DOMAIN IMAGING PROBES AND METHODS OF USE THEREOF | Sep 11, 2022 | Pending |
Array
(
[id] => 18251886
[patent_doc_number] => 20230078925
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => PULSATILE DRUG DELIVERY SYSTEM FOR TREATING MORNING AKINESIA
[patent_app_type] => utility
[patent_app_number] => 17/930169
[patent_app_country] => US
[patent_app_date] => 2022-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12979
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17930169
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/930169 | PULSATILE DRUG DELIVERY SYSTEM FOR TREATING MORNING AKINESIA | Sep 6, 2022 | Abandoned |
Array
(
[id] => 20335451
[patent_doc_number] => 20250339571
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-11-06
[patent_title] => RADIOIMMUNOCONJUGATES TARGETING PHOSPHATIDYLSERINE FOR USE IN THE TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 18/685667
[patent_app_country] => US
[patent_app_date] => 2022-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30634
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18685667
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/685667 | RADIOIMMUNOCONJUGATES TARGETING PHOSPHATIDYLSERINE FOR USE IN THE TREATMENT OF CANCER | Aug 27, 2022 | Pending |
Array
(
[id] => 19570491
[patent_doc_number] => 20240374783
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-14
[patent_title] => COMPOSITION OF AT LEAST A RADIOPAQUE AGENT, METHOD FOR ITS PRODUCTION AND FILLING MATERIAL COMPRISING SUCH COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/690086
[patent_app_country] => US
[patent_app_date] => 2022-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8147
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18690086
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/690086 | COMPOSITION OF AT LEAST A RADIOPAQUE AGENT, METHOD FOR ITS PRODUCTION AND FILLING MATERIAL COMPRISING SUCH COMPOSITION | Aug 23, 2022 | Pending |
Array
(
[id] => 18075745
[patent_doc_number] => 20220401357
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => STARCH-FREE SOFT CHEW FOR VETERINARY APPLICATIONS
[patent_app_type] => utility
[patent_app_number] => 17/821680
[patent_app_country] => US
[patent_app_date] => 2022-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16454
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17821680
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/821680 | Starch-free soft chew for veterinary applications | Aug 22, 2022 | Issued |
Array
(
[id] => 18056548
[patent_doc_number] => 20220387634
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => REDUCED METASTABLE COMPLEX MACROCYCLIC CONTRAST AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/891391
[patent_app_country] => US
[patent_app_date] => 2022-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9768
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17891391
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/891391 | REDUCED METASTABLE COMPLEX MACROCYCLIC CONTRAST AGENTS | Aug 18, 2022 | Pending |
Array
(
[id] => 19799065
[patent_doc_number] => 20250064990
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-27
[patent_title] => METHODS OF SCREENING FOR VMAT2 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 18/684426
[patent_app_country] => US
[patent_app_date] => 2022-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20992
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -72
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18684426
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/684426 | METHODS OF SCREENING FOR VMAT2 INHIBITORS | Aug 17, 2022 | Pending |
Array
(
[id] => 19331379
[patent_doc_number] => 20240245809
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-25
[patent_title] => A CONTRAST AGENT FOR MRI IMAGING DIAGNOSTICS
[patent_app_type] => utility
[patent_app_number] => 18/573534
[patent_app_country] => US
[patent_app_date] => 2022-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5790
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18573534
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/573534 | A CONTRAST AGENT FOR MRI IMAGING DIAGNOSTICS | Jun 22, 2022 | Pending |
Array
(
[id] => 19431095
[patent_doc_number] => 20240299593
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-12
[patent_title] => SYSTEMS AND METHODS FOR GENERATION OF HYPERPOLARIZED MATERIALS
[patent_app_type] => utility
[patent_app_number] => 18/573662
[patent_app_country] => US
[patent_app_date] => 2022-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28031
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18573662
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/573662 | SYSTEMS AND METHODS FOR GENERATION OF HYPERPOLARIZED MATERIALS | Jun 21, 2022 | Pending |
Array
(
[id] => 19387726
[patent_doc_number] => 20240277596
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-22
[patent_title] => CARBOXYLIC ACID LOADED SALT CARRIER AND THE METHOD FOR PRODUCING THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/567702
[patent_app_country] => US
[patent_app_date] => 2022-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21649
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18567702
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/567702 | Carboxylic acid loaded salt carrier and the method for producing thereof | Jun 9, 2022 | Issued |
Array
(
[id] => 18483694
[patent_doc_number] => 20230210996
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => NANOSATELLITE-SUBSTRATE COMPLEX AND METHOD OF REGULATING MACROPHAGE ADHESION AND POLARIZATION USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/834314
[patent_app_country] => US
[patent_app_date] => 2022-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19419
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17834314
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/834314 | NANOSATELLITE-SUBSTRATE COMPLEX AND METHOD OF REGULATING MACROPHAGE ADHESION AND POLARIZATION USING THE SAME | Jun 6, 2022 | Pending |
Array
(
[id] => 18003633
[patent_doc_number] => 20220362399
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => COMPOSITIONS AND ARTICLES COMPRISING (NANO)DIAMOND PARTICLES
[patent_app_type] => utility
[patent_app_number] => 17/751924
[patent_app_country] => US
[patent_app_date] => 2022-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22164
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17751924
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/751924 | COMPOSITIONS AND ARTICLES COMPRISING (NANO)DIAMOND PARTICLES | May 23, 2022 | Abandoned |
Array
(
[id] => 18107901
[patent_doc_number] => 20230000781
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => Dry Powder Formulations for Messenger RNA
[patent_app_type] => utility
[patent_app_number] => 17/745428
[patent_app_country] => US
[patent_app_date] => 2022-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27158
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17745428
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/745428 | Dry powder formulations for messenger RNA | May 15, 2022 | Issued |
Array
(
[id] => 19318281
[patent_doc_number] => 20240239823
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-18
[patent_title] => PHOSPHINATE ESTER-CONTAINING DYES HAVING TUNABLE PROPERTIES AND METHODS OF MAKING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/556703
[patent_app_country] => US
[patent_app_date] => 2022-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26747
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18556703
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/556703 | PHOSPHINATE ESTER-CONTAINING DYES HAVING TUNABLE PROPERTIES AND METHODS OF MAKING THE SAME | May 9, 2022 | Pending |
Array
(
[id] => 19263761
[patent_doc_number] => 20240207458
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-27
[patent_title] => TARGETED ALPHA PARTICLE THERAPY FOR SOMATOSTATIN RECEPTOR 2 POSITIVE NEUROENDOCRINE TUMORS AND METASTASES
[patent_app_type] => utility
[patent_app_number] => 18/556938
[patent_app_country] => US
[patent_app_date] => 2022-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10518
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18556938
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/556938 | TARGETED ALPHA PARTICLE THERAPY FOR SOMATOSTATIN RECEPTOR 2 POSITIVE NEUROENDOCRINE TUMORS AND METASTASES | Apr 25, 2022 | Pending |
Array
(
[id] => 19186367
[patent_doc_number] => 20240165280
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-23
[patent_title] => METHODS FOR TREATMENT OF CANCERS
[patent_app_type] => utility
[patent_app_number] => 17/777850
[patent_app_country] => US
[patent_app_date] => 2022-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6705
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17777850
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/777850 | METHODS FOR TREATMENT OF CANCERS | Apr 21, 2022 | Abandoned |
Array
(
[id] => 18535893
[patent_doc_number] => 20230240979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => TREATMENTS FOR BENIGN PROSTATIC HYPERPLASIA
[patent_app_type] => utility
[patent_app_number] => 17/727680
[patent_app_country] => US
[patent_app_date] => 2022-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20278
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17727680
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/727680 | Treatments for benign prostatic hyperplasia | Apr 21, 2022 | Issued |